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CHALLENGING SITUATIONS IN PARTIAL 
NEPHRECTOMY 
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Abstract 
 
Although most partial nephrectomies are performed as primary procedures in 
the elective or semi-imperative setting on kidneys with relatively normal 
anatomy, this is not always the case. 
 
The indications for partial nephrectomy continue to expand and it is becoming 
particularly relevant in patients with single functioning kidneys, poor kidney 
function, anatomical anomalies and hereditary syndromes predisposing to 
multiple kidney cancers, such as Von Hippel-Lindau syndrome. These, along 
with previous abdominal surgery, pose surgical challenges. In this article we 
offer advice as to how to tackle these unusual situations. 
 
An ability to master the whole range of indications will allow the modern upper 
renal tract surgeon to offer partial nephrectomy to a wider range of patients. 
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Challenging Situations in Partial Nephrectomy 
 
 
The growing detection of asymptomatic small renal masses has resulted in a 
significant stage migration of RCC[1]. Greater recognition of the importance of 
preservation of renal function alongside cancer control has further shifted 
treatment towards nephron sparing techniques. For T1 tumours in healthy 
patients, partial nephrectomy is now considered the standard treatment. 
Superior functional and equivalent oncological outcomes mean it is favoured 
over radical surgery for both T1a and T1b when feasible[2]. The development 
and increasing use of minimally invasive techniques continue to extend these 
indications even in those patients previously considered too complex or 
technically difficult. The key challenging situations a renal surgeon may face 
are outlined in this article together with advice on how these particular 
circumstances should be handled. 
 
 
Prior Abdominal Surgery  
 
Prior abdominal surgery can present a difficult situation for the robotic 
surgeon.  It has been shown to increase the risk of intra-abdominal adhesions 
making access difficult or even impossible[3].  Patients need to be consented 
appropriately and understand the increased risk of conversion to open surgery 
and injury to vascular or visceral structures in particularly to bowel. Prior 
abdominal surgery has been shown to be associated with increased operative 
times and complication rates during laparoscopic surgery[4,5].   
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Thorough preoperative planning involving the whole surgical team is vital. 
Understanding exactly what previous surgery was performed, the technique 
and indication is paramount.  For example large bowel operations, ruptured 
appendix and inflammatory bowel diseases are more likely to cause greater 
adhesions[6].  
 
In difficult cases it is sensible to choose the most experienced nursing staff 
and assistant for such cases.  A reliable, familiar team who understands the 
intricacies of robotic surgery and can troubleshoot unexpected problems is 
very important in these situations. 
 
The next step is to decide on which approach to take.  A retroperitoneal 
approach may be more suited if the patient has had prior intra-peritoneal 
abdominal surgery, particularly when faced with posterior renal tumours.  Its 
disadvantages are the lack of space and that it is often a less familiar 
approach for the surgeon. Camera port placement allows the surgeon to 
assess the amount of adhesions and whether the remaining ports can be 
inserted safely. 
 
Several techniques can be used to gain access.  No device or technique is 
perfectly safe and there is no consensus regarding the optimal choice, 
although if in doubt, the open Hassan technique is likely to be safer than a 
blind Veress needle insertion. If using a Veress needle technique, it should be 
inserted at a distant site to previous incisions. Optical trocars are not 
recommended in these situations due to increased risks of bowel injury. 
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The remaining instrument ports are then triangulated.  Knowledge of optimal 
distances is important to prevent the robotic arms from clashing. Ports need to 
be at least 8 cm apart and 10-20cm from the target anatomy when using the 
da Vinci Si.  With the new Da Vinci Xi, ports can be as close as 6 cm.  
Tapping the skin at the intended insertion site helps the surgeon to visually 
determine if it is safe to place a trocar.  If unsure, a spinal needle can be 
inserted through the skin and its trajectory can be followed with the camera to 
ensure there is no interposed bowel.  An advantage of the Xi is that the 
camera can be inserted through any of the robotic ports, allowing the surgeon 
to visualize the insertion of other ports from different angles.  This is 
particularly useful when placing the assistant ports in the presence of intra-
peritoneal adhesions. 
 
Adhesiolysis with laparoscopic scissors may be required to allow safe 
placement of additional robotic ports after placement of initial trocar. It may be 
easier to dock one robotic arm first and use the robotic scissors to safely 
divide adhesions before docking the remaining arms.  
A recent study on previous abdominal surgery (PAS) and robotic partial 
nephrectomy retrospectively analysed 1686 patients who had undergone RPN 
from an American multi-centre prospective database from 5 large academic 
institutions[7]. A sub-group of 216 patients (13%) had undergone “major 
previous abdominal surgery” (PAS); defined as those marked by upper 
midline or ipsilateral incisions.  The list of prior surgeries is wide ranging with 
12% (n=25) having multiple previous procedures and many others having 
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laparotomies, open cholecystectomies and open ipsilateral partial 
nephrectomies.  11% had a retroperitoneal approach in the PAS group 
compared with 5.4% in the control arm. 
The study found that there was no difference between intraoperative and 
post-operative complications (<4% Clavien ≥3 in PAS group), positive surgical 
margins and change in renal function. Their initial concern that previous 
surgery increases robotic operative time was ill founded as there was no 
statistical difference in median operative times (PAS 172mins (132-224) vs no 
PAS169mins (139-208)). However, they did find statistical difference in 
estimated blood loss, which was higher in the PAS group (150ml vs 100ml 
p=0.039), but this did not translate to a difference in transfusion rates.  
They also found the PAS patients were older (median 63 vs 60years) and had 
a higher median BMI (30.3 vs 29). This is an important finding in the context 
of offering robotic minimally invasive surgery in an increasingly obese and 
ageing surgical population.  
Another study on transperitoneal robotic partial nephrectomy showed that 
patients with prior abdominal surgery were more likely to require adhesiolysis 
(41% vs 15%, P = 0.005).  Adhesiolysis took a mean time of 32 min but there 
was no statistical difference in overall operative time however. In the prior 
abdominal surgery group, there was a trend toward longer median warm 
ischaemia time (21 vs 16 min) and median estimated blood loss (150 vs 100 
ml), without reaching statistical significance. There was no significant 
difference in intra or post operative complications[3]. Transperitoneal robotic 
partial nephrectomy therefore is feasible in the setting of prior abdominal 
surgery. 
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Single Functional Kidney 
 
One of the most common challenging situations a renal surgeon will 
encounter is that of the patient with the single functioning kidney. Close 
attention needs to be taken to manage the discordant risks of renal cancer 
and chronic renal failure with its attendant cardiovascular risk and 
increased mortality[8]. The two primary aims are to achieve adequate 
tumour resection whilst maintaining sufficient renal function. Chronic 
kidney disease is encountered in a large proportion of patients with small 
renal masses[9], but the significantly lower preoperative estimated 
glomerular filtration rate (eGFR) of patients with solitary kidneys highlights 
their vulnerability[10]. A single functioning kidney is one of the most 
significant risk factors for developing renal failure following nephron 
sparing surgery (NSS)[11].  
 
Partial nephrectomy, despite the risks, is a feasible management option 
but the factors affecting post operative eGFR remain under debate[10,12-
14]. La Rochelle et al found that the only relevant variables were cold 
ischaemia time and the presence of cardiovascular risk factors[12]. 
Furthermore these factors only affected immediate post-operative renal 
function; none were associated with long-term eGFR. The lack of effect of 
tumour size was also reported in another single centre study however the 
authors did show that clamp time and blood loss were significant predictors 
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of post operative eGFR[10]. Again no factors were found to impact the 
long-term eGFR. Concerns regarding prolonged ischaemia remain valid in 
the immediate post operative especially in the setting of preoperative renal 
impairment[15-18]. However large studies have found that in the long term, 
ultimate renal function is primarily determined by the amount of 
parenchymal loss not the degree of ischaemia injury[13,16]. After an initial 
post operative fall in eGFR, studies have shown that long term renal 
function remains relatively stable following partial nephrectomy[10,12,13]. 
Thankfully the need long term dialysis remains uncommon[12-14,19]. 
Those patients with lower preoperative eGFR are at a greater risk of end 
stage renal disease (ESRD)[12]. 
 
Oncological safety is paramount in NSS on solitary kidneys. Given the 
bleak outcomes for patients on dialysis, avoiding radical nephrectomy is 
vital[20]. The most significant risk factors to developing ESRD are 
inadequate resection and local recurrence[13]. Positive surgical margin 
(PSM) rates have been found to be higher in solitary kidney patients 
compared to patients with normal contralateral kidneys but its significance 
is contentious. There is evidence to suggest that PSM have negligible 
effects on development of metastasis[21] whilst other authors argue that 
PSM do increase the risk of metastasis[22]. As a result although it is 
argued that tumour enucleation can offer equivalent outcomes as partial 
nephrectomy, the balance appears to be moving in favour of performing an 
adequate resection to minimise the risk of a PSM[23]. 
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Overall NSS in solitary kidneys has been shown to be effective with 5 year 
cancer specific survival rates of 77.5-95.1% (table 1). Given survival rates 
of dialysis patients are less than half, it can be argued that NSS is 
imperative in appropriate patients in the setting of a single functioning 
kidney[20]. CSS rates are comparable to patients with a normal 
contralateral kidney and lower overall survival rates in solitary kidney 
patients attributed to the morbidity of CKD[14,24]. 
 
Historically an open rather than laparoscopic approach was associated 
with better post operative renal function[25]. LPN has been shown to be 
safe and effective, but success remains dependent both on patient 
selection and the surgeon’s laparoscopic expertise[26]. In open 
approaches ice slush cooling is usually utilised in such cases whilst 
minimally invasive approaches often employ early unclamping or 
segmental clamping techniques to minimise renal ischaemia. Recently a 
robotic assisted ice slush cooling technique has been published which may 
allow more single kidneys to be treated minimally invasively[27]. Whilst it 
remains an advanced procedure, the benefits of the robotic platform help 
overcome a number of the difficulties faced in partial nephrectomy[28]. 
Precise tumour resection and a faster renorrhaphy help reduce renal 
injury. 
 
As with ‘routine’ small renal masses, thermal ablation (TA) offers an 
alternative treatment option. Given the scarcity of cases, data on 
experience and outcomes for TA in solitary kidneys remains limited. 
 10 
Analysis of available observational data shows that whilst PN offers better 
cancer control, TA is associated with better preservation of renal function 
and lower complications, thereby offering a viable option for those patients 
with increased co-morbidity or otherwise unsuitable to undergo PN[29]. 
 
 
Von Hippel-Lindau Syndrome 
 
Von Hippel-Lindau (VHL) syndrome is the most common hereditary renal 
cell carcinoma (RCC) syndrome. Inherited in an autosomal dominant 
fashion, loss of the VHL gene leads to the accumulation and over 
expression of hypoxia inducible factor 1 (HIF-1) and consequently tumour 
formation. Amongst the various clinical manifestations, renal cell 
carcinoma is one of the most common and a leading cause of 
mortality[30]. Surgical management of hereditary, multifocal tumours such 
as VHL focuses on preventing metastatic disease whilst maintaining native 
renal function for as long as possible. Effective screening is an essential 
component of management starting with annual ultrasounds during 
childhood before progressing to yearly contrast enhanced CT scans from 
18 years[31]. Historically patients with multifocal and recurrent hereditary 
tumours were managed with bilateral nephrectomy and dialysis with a view 
to transplantation. However developments in nephron sparing surgery 
together with shortages of donor organs and recognition of the morbidity of 
even short periods of dialysis has lead to the development of new surgical 
approaches.  
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Managing VHL patients with small renal masses centres on accurate 
diagnosis. When possible renal biopsy should be performed to provide a 
histological diagnosis as well as for genetic testing[32]. Split renal function 
needs to be assessed to establish baseline renal function and guide 
subsequent treatment.  
 
Surgical intervention requires careful consideration to minimise renal tissue 
loss. In this setting bilateral partial nephrectomies are indicated and may 
be performed either as a staged procedure or simultaneously, the latter 
becoming increasingly common. If a staged strategy is used, the largest 
tumour is usually resected first given the greater risk of metastasis[33]. On 
the other hand some surgeons elect to operate on less complicated tumour 
first. Laparoscopic and robotic techniques have been shown to be feasible 
in treating multiple renal tumours however their use must not come at the 
expense of oncological clearance[34,35]. 
 
When planning surgery, the 3cm rule is often applied to hereditary renal 
cell carcinomas.  Developed for VHL patients, it dictates that only solid 
tumours over 3cm are treated as compromise between oncological safety 
and nephron preservation and to delay surgery and potential dialysis as 
long as possible[33,36]. Given the negligible effects of a positive margin in 
such small renal masses together with the need to maximise residual renal 
parenchyma, enucleation is considered a safe and sensible 
technique[37,38]. Patients are highly likely to require further surgery so 
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liberal renal hilar dissection and vascular clamping needs careful 
consideration. Many surgeons favour non-ischaemic dissection to reduce 
ischaemic injury but competent assistance during dissection is crucial for 
maintaining a clear surgical field. Larger bleeding vessels should be 
individually sutured whilst smaller vessels and generalised bleeding 
managed with haemostatic agents. Avoiding non-specific cautery 
especially at the base of the defect helps protect segmental vascular 
supply. Minimising dissection of the kidney and preservation of Gerota’s 
fascia with a clam shell incision can help reduce adhesions, adherence of 
the kidney to the abdominal wall, and the chance of fistula formation 
between multiple defects[32]. It is also advised to replace Gerota’s fascia 
around the kidney on closure to reduce scarring. If revision surgery is then 
required at a later stage, these authors recommend altering the approach. 
If an open flank incision were made, then a transperitoneal approach 
would be recommend. Likewise following a primary laparoscopic or robotic 
transperitoneal partial nephrectomy, retroperitoneal revision surgery 
should be considered. 
 
Ablative techniques are increasingly being used for treating VHL, 
particularly smaller, recurrent tumours. Ablation allows repeated 
interventions with greater preservation of renal function compared to NSS. 
Both cryotherapy and radiofrequency ablation (RFA) have been used 
effectively in treating VHL patients[39,40] and combined with PN[41]. 
   
Careful, targeted management of hereditary RCC syndromes such as VHL 
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has been supported by various studies. Herring et al reported their 10 year 
experience of managing 50 patients none of whom required dialysis and 
only one developed metastatic disease[42]. Roupert and Walther et al 
reported similarly good results with no metastatic progression[36,43].  
 
Horseshoe Kidney 
 
There are a few reported cases of robotic surgery performed for small 
renal masses in horseshoe kidneys.  With an incidence rate of 1 in 400 
and a 2:1 ratio in men, horseshoe kidneys are the most common renal 
fusion anomaly.  They appear more often with chromosomal aneuploidies 
(trisomies and Turner syndrome)[44].  Fusion of the inferior portion of the 
metanephric blastema during the sixth week of gestations forms the 
isthmus.  As a result, renal ascent is limited by the inferior mesenteric 
artery at the level of L3.   
 
As a consequence, the kidneys have medially facing lower pole calyces, 
malrotation with calyces facing more posteriorly and the renal pelvis more 
anteriorly.  Vascular supply is commonly atypical with renal vessels arising 
from any of the aorta, inferior mesenteric artery (IMA), iliac vessels or even 
sacral artery.  Multiple renal arteries are found in 70% of horseshoe kidneys.  
An artery to the isthmus is common; 65% originate from the aorta and 35% 
from the IMA, main renal artery or iliac vessels[45]. The isthmus commonly 
lies anterior to the aorta and vena cava but rarely may pass between the 
inferior vena cava and the aorta or even behind both great vessels. 
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Horseshoe kidneys may also have a high ureteric insertion and the course 
of the ureters is anterior to the isthmus and lateral to lower pole calyces, 
which is a key intravenous pyelogram (IVP) finding.  
 
Although most horseshoe kidneys are asymptomatic, complications can 
include pelviureteric junction obstruction (up to 30%), renal calculi, urinary 
tract infections, vesicoureteric reflux (up to 50%) and a twofold risk of Wilms 
tumour[46]. Rates of other renal tumours are comparable to the general 
population.  Renal cell cancer accounts for 45% of malignant lesions in 
horseshoe kidneys while Wilms’ tumour accounts for 28%[47].  Transitional 
cell cancer and sarcoma account for 20% and 7% of tumours, 
respectively[45,47].  
 
Robotic oncologic surgery in patients with horseshoe kidneys can be 
technically challenging due to the aberrant anatomy. Adequate 
preoperative imaging is crucial. A triple phase CT or MRI with three-
dimensional arterial reconstruction is strongly encouraged.  
 
A skilled bedside assistant with suitable laparoscopic experience is 
important to ensure safe application of clips and staples through a 
standard laparoscopic technique[48].  
 
A robotic partial nephrectomy or heminephrectomy in a horseshoe kidney 
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can be performed using a transperitoneal or a retroperitoneal approach.  
The latter may be essential for posterior tumour as a horseshoe kidney 
does not allow traditional mobilization and flipping of the kidney[49].  
For a transperitoneal approach, the positioning of the patient is similar to 
that used in a standard robotic partial nephrectomy, with the patient in a 
flank position.  The ports however need to be adjusted to be slightly more 
medial and caudal.  A fourth robotic arm is recommended for retraction. 
 
The colon is reflected to expose the aorta and IVC.  The ureter and the 
renal pedicle are then carefully dissected. Anomalous arterial branches are 
identified and dissected out in preparation for hilar clamping.  In a 
horseshoe kidney, most of the vessels are above the isthmus[47].  After 
tumour excision, reconstruction can be performed using standard running 
3-0 monocryl and interrupted 0-Vicryl sutures for the parenchyma and 
capsule, respectively.  It should be noted that even after clamping, the 
kidney is still supplied by the other moiety. This can make dissection very 
challenging, but it does reduce the risk of ischaemic renal injury.   
If a heminephrectomy is required, the kidney should be fully mobilized so 
that the isthmus can be divided.  Several laparoscopic techniques have 
been described such as placing a Satinsky clamp on the isthmus prior to 
sharply dividing it and then running a 2-0 vicryl for parenchyma 
haemostasis[50], or clipping the isthmus with a 15-mm Hem-o-lok, dividing 
it with a Harmonic scalpel then tying a PDS Endoloop around the 
isthmus[47]. Or even transecting the renal isthmus using a laparoscopic 
stapler[48].   
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The challenging anatomic variations of horseshoe kidneys should be 
approached cautiously.  It is recommended that such cases not be 
undertaken by novice and intermediate robotic surgeons.  The few 
reported cases in the literature of robotic partial nephrectomy or 
heminephrectomy in a horseshoe kidney show that the procedure is 
feasible and safe in expert hands.  However, meticulous attention to the 
patient’s vascular anatomy via high quality vascular reconstruction CT 
imaging is paramount to avoid bleeding complications.  Port placement 
needs to be individualized to avoid instrument clashing and to facilitate 
optimal access to the kidney[51].  
 
Ectopic Pelvic Kidneys 
 
Ectopic pelvic kidneys are uncommon, presenting in 1/10,000 patients 
whilst autopsy studies estimate their true prevalence as up to 1/1000[52]. 
With their short, torturous ureters pelvic kidneys are more susceptible to 
infection, calculi and obstruction. They do not confer an increased 
malignancy risk but cases of renal cell carcinoma in pelvic kidneys have 
been reported. Treatment should adhere to the general principles of 
oncological management although a number of aspects need careful 
consideration.  
 
Laparoscopic surgery on pelvic kidneys is feasible with evidence from a 
number of case series[53-56].  The altered anatomy of the pelvic kidney 
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poses a number of challenges to the surgeon. Firstly the kidney is usually 
buried deep within the pelvis below the aortic bifurcation and hidden by the 
sacrum if approaching from the abdomen.  The ectopic position of the 
hilum and malrotation of the kidney make dissection especially within the 
confines of the pelvis[56]. Ectopic kidneys maybe associated with other 
anatomical abnormalities of the vertebral column, gastrointestinal and 
urogenital tract altering anatomy and complicating access[45].   Secondly 
the vasculature, dependent on the position of the kidney, is also liable to 
be highly variable[57]. The arterial supply may originate from the distal 
aorta, aortic bifurcation, common or external iliacs or even the inferior 
mesenteric vessels.  Preoperative angiography is therefore recommended 
to help delineate the anomalous vasculature[55-57]. Nevertheless 
intraoperatively careful but extensive dissection is necessary to prevent 
inadvertent injury to major pelvic vessels and ureters[55].  
 
Only a single case of a open partial nephrectomy in a pelvic kidney has 
been reported in the literature [58]. Aside from this, the literature in 
managing renal masses in pelvic kidneys is restricted to individual case 
reports of laparoscopic nephrectomies[54].  The rare issue of a renal 
tumour within a functioning transplant can occasionally occur[59]. As for 
other special situations high quality renal and vascular imaging is required. 
A open approach is generally needed with ice slush cooling or non-clamp 
techniques employed to minimise ischaemic damage. It is wise to pre-
operatively stent the transplant ureter to minimise the risk of urine leak and 
to bear in mind the longer healing times required for patients on 
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immunosuppression when managing these patients post- operatively.  
 
Conclusions 
With increasing numbers of patients undergoing partial nephrectomy, the 
occurrence of some of these special situations is increasing. Whilst the 
principles remain the same as the standard situations special attention 
should be paid to pre-operative imaging, multi-disciplinary discussions of 
all treatment options and referral to highly experienced teams if possible. 
Generally careful choice of approach and access is key in cases of prior 
surgery, warm ischaemia should be minimised in poorly functioning 
kidneys, and aberrant anatomy appreciated in anomalies of fusion and 
ascent.  
As experience increases these special situations will increasingly become 
part of the repertoire of the kidney surgeon. 
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Table 1 Outcomes for Partial Nephrectomy in Single Kidneys 
Study Date Approach Outcomes 
Ghoneim et 
al[10] 
2015 Open Partial Nephrectomy, n = 103 5 year OS = 64% 
5 year CSS = 81% 
Ching[13] 2013 Open Partial Nephrectomy, n = 282 5 year OS = 78.5% 
5 year CSS = 95.1% 
5 year RFS = 75.4% 
10 year OS = 59.5% 
10 year CSS = 91.9% 
10 year RFS = 70.8% 
Lee et al[19] 2011 Open Partial Nephrectomy, n=38 5 year OS = 59.6% 
5 year CSS = 77.5% 
5 year RFS = 45.7% 
La 
Rochelle[12] 
2009 Open Partial Nephrectomy, n = 68 5 year CSS = 89% 
(no prior metastatic 
disease) 
 24 
 Pahernik[60] 2007 Open Partial Nephrectomy, n = 103 5 year OS = 80.1% 
5 year CSS = 89.6% 
10 year OS = 54.1% 
10 year CSS = 76% 
Fergany[61] 2006 Open Partial Nephrectomy, n = 400 5 year OS = 87% 
5 year CSS = 89% 
10 year OS = 77% 
10 year CSS = 82% 
Saranchuk[14
] 
2004 Open Partial Nephrectomy, n = 54 5 year OS = 68% 
5 year CSS = 88% 
5 year RFS = 73% 
Ghavamian et 
al[24] 
2002 Open Enucleation, n  = 23 
Open Partial Nephrectomy, n = 24 
Both  = 7 
Ex Vivo tumour resection = 8 
5 year OS = 74.7% 
5 year CSS = 80.7% 
10 year OS = 45.8 
10 year CSS = 63.7% 
 
OSS: Overall Survival, RFS: Recurrence Free Survival, CSS: Cancer Specific Survival 
 
 
 
 
 
